-transparent.png){kind=logo}
The discovery of human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) has opened a window to the understanding of the spectrum of the acquired immunodeficiency syndrome (AIDS) and related clinical syndromes. Analysis of risk factors for seropositivity has shown that HTLV-III is transmitted most efficiently via routes that involve close personal contact or parenteral exposure. Longitudinal studies have shown that HTLV-III infection has a long latent period. The prevalence of AIDS in different geographic areas and among different risk groups appears to depend in part on duration of exposure. Co-factors for AIDS outcome such as manner and route of exposure, underlying immune status, and host susceptibility are also likely to play a role in risk.
W A Blattner, and
R J Biggar, and
S H Weiss, and
M Melbye, and
J J Goedert
January 1984,
Princess Takamatsu symposia,
W A Blattner, and
R J Biggar, and
S H Weiss, and
M Melbye, and
J J Goedert
June 1984,
Lancet (London, England),
W A Blattner, and
R J Biggar, and
S H Weiss, and
M Melbye, and
J J Goedert
September 1985,
Blood,
W A Blattner, and
R J Biggar, and
S H Weiss, and
M Melbye, and
J J Goedert
September 1985,
Lancet (London, England),
W A Blattner, and
R J Biggar, and
S H Weiss, and
M Melbye, and
J J Goedert
September 1985,
JAMA,
W A Blattner, and
R J Biggar, and
S H Weiss, and
M Melbye, and
J J Goedert
May 1992,
Human pathology,
W A Blattner, and
R J Biggar, and
S H Weiss, and
M Melbye, and
J J Goedert
March 1986,
Blood,
W A Blattner, and
R J Biggar, and
S H Weiss, and
M Melbye, and
J J Goedert
April 1986,
Journal of virology,
W A Blattner, and
R J Biggar, and
S H Weiss, and
M Melbye, and
J J Goedert
October 1985,
Connecticut medicine,
W A Blattner, and
R J Biggar, and
S H Weiss, and
M Melbye, and
J J Goedert
December 1985,
MMWR. Morbidity and mortality weekly report,
